Literature DB >> 8144937

Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1.

S Sozzani1, D Zhou, M Locati, M Rieppi, P Proost, M Magazin, N Vita, J van Damme, A Mantovani.   

Abstract

MCP-2 and MCP-3 are recently identified members of the Cys-Cys chemokine family with high sequence similarity with MCP-1 (62% and 71%, respectively). The present study was aimed at defining receptor usage and signal transduction pathways of MCP-2 and MCP-3 in human monocytes in comparison with MCP-1. MCP-2 and MCP-3 induced migration of monocytes with a typical bell-shaped curve and maximal response at 10 and 50 ng/ml, respectively. The maximal response elicited by MCP-2 and MCP-3 was lower (approximately 60%) than that of MCP-1. Pertussis toxin (PTox) inhibited the chemotactic activity of MCP-3 and MCP-1 (IC50 = 6.2 and 4.4 ng/ml, respectively), whereas cholera toxin (CTox) had little effect on these two chemokines (IC50 > 1000 ng/ml). In contrast, MCP-2-induced chemotaxis was blocked by CTox (IC50 = 75 ng/ml) and relatively unaffected by PTox. MCP-3 and MCP-1 induced a rapid increase in intracellular Ca2+ concentration, whereas MCP-2, in the range of concentrations active on chemotaxis, did not. MCP-1-, MCP-2-, and MCP-3-induced chemotactic responses were blocked by C-I, a serine/threonine kinase inhibitor, and by genistein, a tyrosine kinase inhibitor, with the MCP-2 response being more sensitive than those induced by MCP-1 and MCP-3. MCP-1 and MCP-3 rapidly induced arachidonic acid release whereas MCP-2 was ineffective. MCP-1 and MCP-3 cross-desensitized with each other in terms of Ca2+ transients and displaced with a comparable efficiency labeled MCP-1 from human monocytes. On the other hand, MCP-2 did not cross-desensitize with MCP-1 and MCP-3 and only partially (20%) displaced labeled MCP-1. Thus, in spite of high sequence similarity, MCP-2 differed considerably from MCP-1 and MCP-3 in terms of sensitivity to CTox and PTox, arachidonate and calcium mobilization, and capacity to compete for labeled MCP-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144937

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes.

Authors:  R Zamarchi; P Allavena; A Borsetti; L Stievano; V Tosello; N Marcato; G Esposito; V Roni; C Paganin; G Bianchi; F Titti; P Verani; G Gerosa; A Amadori
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

Authors:  J H Wain; J A Kirby; S Ali
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Murine astrocytes express a functional chemokine receptor.

Authors:  S Tanabe; M Heesen; M A Berman; M B Fischer; I Yoshizawa; Y Luo; M E Dorf
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

4.  Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

Authors:  Yeny Martinez de la Torre; Chiara Buracchi; Elena M Borroni; Jana Dupor; Raffaella Bonecchi; Manuela Nebuloni; Fabio Pasqualini; Andrea Doni; Eleonora Lauri; Chiara Agostinis; Roberta Bulla; Donald N Cook; Bodduluri Haribabu; Pierluigi Meroni; Daniel Rukavina; Luca Vago; Francesco Tedesco; Annunciata Vecchi; Sergio A Lira; Massimo Locati; Alberto Mantovani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

5.  HIV-1 Tat protein mimicry of chemokines.

Authors:  A Albini; S Ferrini; R Benelli; S Sforzini; D Giunciuglio; M G Aluigi; A E Proudfoot; S Alouani; T N Wells; G Mariani; R L Rabin; J M Farber; D M Noonan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

6.  C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms.

Authors:  L E Leigh; B Ghebrehiwet; T P Perera; I N Bird; P Strong; U Kishore; K B Reid; P Eggleton
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

7.  Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists.

Authors:  Elena Riboldi; Giada Frascaroli; Pietro Transidico; Walter Luini; Sergio Bernasconi; Francesca Mancini; Angelo Guglielmotti; Claudio Milanese; Mario Pinza; Silvano Sozzani; Alberto Mantovani
Journal:  Br J Pharmacol       Date:  2003-08-18       Impact factor: 8.739

Review 8.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

9.  Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection.

Authors:  M A Billstrom; G L Johnson; N J Avdi; G S Worthen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 10.  Correlation between MCP-1-2518A/G polymorphism and the risk of Alzheimer's disease.

Authors:  Yan Wang; Siyi Huang; Xiaoling Wu; Yong Wang; Deqi Jiang
Journal:  J Neural Transm (Vienna)       Date:  2018-10-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.